| 25 February 2014 | Presentation of the fourth quarter 2013 report |
| 13 May 2014 | First quarter 2014 report |
| 13 May 2014 | Annual General Meeting |
| 19 August 2014 | Presentation of the second quarter 2014 report |
| 04 November 2014 | Third quarter 2014 report |
For further information, please contact:
Ronny Skuggedal
CFO/IRO
Email: rs@pcibiotech.no
Mobile +47 9400 5757
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Recommended Reading
-
Oslo (Norway), 29 January 2026 – PCI Biotech (OSE: PCIB) refers to its latest announcement of 8 January 2026 regarding the discontinuation of all R&D operations and the continued exploration of...
Read More -
Oslo (Norway), 8 January 2026 – PCI Biotech (OSE: PCIB). Reference is made to the company’s latest announcement dated 23rd October 2025. The external evaluation of a new bioprocessing technology has...
Read More